2015
DOI: 10.7196/samj.2015.v105i12.10341
|View full text |Cite
|
Sign up to set email alerts
|

A clinical update on paediatric lupus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
2
0
2

Year Published

2019
2019
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 25 publications
0
2
0
2
Order By: Relevance
“…Diagnosis can be challenging where infections (such as TB) are often mimics of rheumatic diseases and diagnostic capabilities (including availability of autoantibody tests) are often limited in low resource settings [ 5 , 95 ]. Delayed diagnosis and access to specialist care in JSLE with worse clinical outcomes is widely reported across the world [ 79 , 88 , [96] , [97] , [98] ], often associated with more severe disease activity and organ damage at presentation [ 75 , 99 , 100 ]. Many of the innovations that have improved survival in HRIC remain unavailable in most of the world [ 77 ] and access to renal replacement therapy may be severely limited or non-existent [ 101 ].…”
Section: Impact Described Through Selected Msk Conditionsmentioning
confidence: 99%
“…Diagnosis can be challenging where infections (such as TB) are often mimics of rheumatic diseases and diagnostic capabilities (including availability of autoantibody tests) are often limited in low resource settings [ 5 , 95 ]. Delayed diagnosis and access to specialist care in JSLE with worse clinical outcomes is widely reported across the world [ 79 , 88 , [96] , [97] , [98] ], often associated with more severe disease activity and organ damage at presentation [ 75 , 99 , 100 ]. Many of the innovations that have improved survival in HRIC remain unavailable in most of the world [ 77 ] and access to renal replacement therapy may be severely limited or non-existent [ 101 ].…”
Section: Impact Described Through Selected Msk Conditionsmentioning
confidence: 99%
“…JSLE is a multisystem disease with serious, potentially life threatening organ involvement [21][22][23][24] and reported to be more common and severe in non-Caucasians with worse clinical outcomes [21,23,[25][26][27]; to our knowledge there are no population based prevalence studies in Asia or Africa. For the purpose of this study, we have assumed a prevalence of 10 in 100,000 based on the United States (US) Medicaid programme covering a multi-racial population [22]; we have not attempted to address variation in prevalence estimates by age, gender or ethnicity.…”
Section: Msk Conditionsmentioning
confidence: 97%
“…Pemeriksaan anti-dsDNA memiliki spesifitas tinggi dan sensitivitas hingga 70% dalam mendiagnosis LES sehingga sering dijadikan pemeriksaan penunjang diagnosis LES pada pasien. 17 Selain itu, penelitian oleh Kone dkk 18 juga menunjukkan bahwa 90% pasien anak LES memiliki peningkatan anti-dsDNA positif. Pemeriksaan ANA profile digunakan untuk mengukur kadar dan pola aktivitas antibodi pada darah dengan menggunakan prosedur imunofluorescence indirect dengan menggunakan sel Hep-2.…”
Section: Pembahasanunclassified
“…19 Pada saat anak terdiagnosis LES, seringkali hasil tes ANA menunjukkan hasil positif. 17 Hasil penelitian ini didukung oleh Muzayanah 20 pada tahun 2016 yang menemukan 91% anak dengan LES memiliki peningkatan kadar ANA di dalam darahnya. 20 Penelitian ini menunjukkan bahwa sebagian besar pasien anak LES di RSUD dr. Zainoel Abidin Banda Aceh memiliki kualitas hidup yang baik (67,6%).…”
Section: Pembahasanunclassified